Literature DB >> 20728070

Association of body mass index with hip and thigh pain following transobturator midurethral sling placement.

Lauren A Cadish1, Michele R Hacker, Laura E Dodge, Patricia Dramitinos, Lekha S Hota, Eman A Elkadry.   

Abstract

OBJECTIVE: We sought to investigate the incidence of hip and proximal lower extremity pain following transobturator midurethral sling and evaluate the association between pain and body mass index (BMI). STUDY
DESIGN: This was a retrospective cohort study of all transobturator midurethral sling procedures from July 2008 through June 2009. The primary outcome was postoperative hip or proximal lower extremity pain.
RESULTS: Four urogynecologists performed 226 procedures. The incidence of postoperative hip or proximal lower extremity pain was 15.5%. Women of normal BMI had a higher risk of developing pain than obese women (risk ratio, 2.51; 95% confidence interval, 1.01-6.22). While not statistically significant, overweight women were twice as likely as obese women to develop the primary outcome (risk ratio, 1.99; 95% confidence interval, 0.79-4.99).
CONCLUSION: Women of normal BMI have an increased risk of hip and proximal lower extremity pain following transobturator midurethral sling compared with obese women.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728070     DOI: 10.1016/j.ajog.2010.07.023

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Characterization of pain after inside-out transobturator midurethral sling.

Authors:  Lauren A Cadish; Michele R Hacker; Anna Merport Modest; Kathleen J Rogers; Sybil Dessie; Eman A Elkadry
Journal:  Female Pelvic Med Reconstr Surg       Date:  2014 Mar-Apr       Impact factor: 2.091

Review 2.  Does body mass index influence the outcome of midurethral sling procedures for stress urinary incontinence?

Authors:  Ziyuan Xia; Jialei Qian; Yuntian Chen; Banghua Liao; Deyi Luo
Journal:  Int Urogynecol J       Date:  2016-11-07       Impact factor: 2.894

3.  Reply to letter to the editor re: Does body mass index influence the outcome of midurethral sling procedures for stress urinary incontinence?

Authors:  Jialei Qian; Deyi Luo
Journal:  Int Urogynecol J       Date:  2017-11-04       Impact factor: 2.894

4.  Association between body mass index and pain following transobturator sling.

Authors:  Lauren A Cadish; Michele R Hacker; Anna M Modest; Kathleen J Rogers; Sybil Dessie; Eman A Elkadry
Journal:  J Obstet Gynaecol       Date:  2017-04-01       Impact factor: 1.246

5.  Long-term outcomes of the Ajust Adjustable Single-Incision Sling for the treatment of stress urinary incontinence.

Authors:  Gert Naumann; Thomas Hagemeier; Stefan Zachmann; Aktham Al-Ani; Stefan Albrich; Christine Skala; Rosa Laterza; Misti Linaberry; Heinz Koelbl
Journal:  Int Urogynecol J       Date:  2012-06-16       Impact factor: 2.894

6.  The influence of the modifiable life-style factors body mass index and smoking on the outcome of mid-urethral sling procedures for female urinary incontinence.

Authors:  Katja Stenström Bohlin; Maud Ankardal; Corinne Pedroletti; Håkan Lindkvist; Ian Milsom
Journal:  Int Urogynecol J       Date:  2015-01-09       Impact factor: 2.894

Review 7.  Pain after suburethral sling insertion for urinary stress incontinence.

Authors:  Jonathan Duckett; Andrew Baranowski
Journal:  Int Urogynecol J       Date:  2012-07-03       Impact factor: 2.894

8.  Body size and endometriosis: results from 20 years of follow-up within the Nurses' Health Study II prospective cohort.

Authors:  Divya K Shah; Katharine F Correia; Allison F Vitonis; Stacey A Missmer
Journal:  Hum Reprod       Date:  2013-05-14       Impact factor: 6.918

9.  A new titanium-covered transobturator tape for surgical treatment of stress urinary incontinence.

Authors:  Anne-Claude Fahrni; Cornelia Betschart; Jean Bouquet de la Jolinière; Jean-Bernard Dubuisson; Anis Feki; Attila Louis Major
Journal:  Int Urogynecol J       Date:  2021-10-02       Impact factor: 1.932

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.